Cargando…

Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial

IMPORTANCE: RimabotulinumtoxinB (RIMA) may be preferable as an anti-sialorrhea treatment compared with current oral anticholinergic drugs in people with neurological disorders. OBJECTIVE: To assess the safety, efficacy, and tolerability of RIMA injections for the treatment of sialorrhea in adults. D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isaacson, Stuart H., Ondo, William, Jackson, Carlayne E., Trosch, Richard M., Molho, Eric, Pagan, Fernando, Lew, Mark, Dashtipour, Khashayar, Clinch, Thomas, Espay, Alberto J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990829/ https://www.ncbi.nlm.nih.gov/pubmed/31930364 http://dx.doi.org/10.1001/jamaneurol.2019.4565

Ejemplares similares

RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials
por: Dashtipour, Khashayar, et al.
Publicado: (2017)

Transient Improvement after Switch to Low Doses of RimabotulinumtoxinB in Patients Resistant to AbobotulinumtoxinA
por: Hefter, Harald, et al.
Publicado: (2020)

Sialorrhea in Parkinson’s Disease
por: Isaacson, Jonathan, et al.
Publicado: (2020)

Efficacy of botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia previously treated with botulinum toxin type A: A post-marketing observational study in Japan
por: Kaji, Ryuji, et al.
Publicado: (2021)

Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease
por: Isaacson, Stuart, et al.
Publicado: (2016)

OnabotulinumtoxinA and AbobotulinumtoxinA Dose Conversion: A Systematic Literature Review
por: Dashtipour, Khashayar, et al.
Publicado: (2015)

Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study
por: Patel, Atul T., et al.
Publicado: (2021)

Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study
por: Patel, Atul T., et al.
Publicado: (2021)

Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease
por: Bergmans, Bruno, et al.
Publicado: (2023)

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
por: Lew, Mark F., et al.
Publicado: (2021)

Lithium-Induced Sialorrhea
por: Johnson, Bamidele O, et al.
Publicado: (2023)

AbobotulinumtoxinA using 2-mL dilution (500 U/2-mL) maintains durable improvement across multiple treatment cycles
por: Dashtipour, Khashayar, et al.
Publicado: (2020)

Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension
por: Isaacson, Stuart H., et al.
Publicado: (2021)

Therapy of Sialorrhea with Botulinum Neurotoxin
por: Jost, Wolfgang H., et al.
Publicado: (2019)

Dealing With Clozapine-Induced Sialorrhea
por: Sá Couto, J., et al.
Publicado: (2022)

SIALORRHEA AND XEROSTOMIA IN PARKINSON’S DISEASE PATIENTS
por: Špiljak, Bruno, et al.
Publicado: (2022)

SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea
por: Jost, Wolfgang H., et al.
Publicado: (2019)

Efficacy of Botulinum Toxin for Treating Sialorrhea in Neuromuscular Conditions
por: Singh, Harsh, et al.
Publicado: (2020)

IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease: The RISE-PD Randomized Clinical Trial
por: Hauser, Robert A., et al.
Publicado: (2023)

Contemporary Surgical Management of Severe Sialorrhea in Children
por: Hornibrook, Jeremy, et al.
Publicado: (2012)

Sialorrhea in patients with ALS: current treatment options
por: Garuti, Giancarlo, et al.
Publicado: (2019)

Current Aspects of Treatment Options of Chronic Sialorrhea in Children
por: Bittmann, Stefan, et al.
Publicado: (2022)

The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea
por: Darriba, H. Becerra
Publicado: (2021)

Pathophysiology and management of risperidone-induced sialorrhea: case report
por: Torrico, Tyler, et al.
Publicado: (2023)

Safety Profile and Lack of Immunogenicity of IncobotulinumtoxinA in Pediatric Spasticity and Sialorrhea: A Pooled Analysis
por: Berweck, Steffen, et al.
Publicado: (2022)

Sialorrhea: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins
por: Lakraj, Amanda Amrita, et al.
Publicado: (2013)

Thrombocytopenia associated with clonidine in a case of clozapine-induced sialorrhea
por: Leung, Jonathan G., et al.
Publicado: (2020)

Neuromuscular Electrical Stimulation for Sialorrhea in an Elderly Woman With Parkinson’s Disease
por: Kojima, Yuki, et al.
Publicado: (2022)

Botulinum toxin in the treatment of sialorrhea in severe neurological patients with tracheotomy
por: Shao, Mengmeng, et al.
Publicado: (2023)

Long-term efficacy of glycopyrrolate on sialorrhea in Goldenhar syndrome: a case report
por: Della Bella, Gessica, et al.
Publicado: (2022)

Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?
por: Isaacson, Stuart H., et al.
Publicado: (2022)

A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia
por: Han, Yi, et al.
Publicado: (2016)

The effectiveness and safety of botulinum toxin injections for the treatment of sialorrhea with Parkinson's disease: a systematic review and meta-analysis
por: Yang, Chun-Lan, et al.
Publicado: (2023)

Incobotulinumtoxin A for Sialorrhea in Neurological Disorders: A Real-Life Experience
por: Martínez-Poles, Javier, et al.
Publicado: (2018)

Placebo-Controlled Clinical Trial of IncobotulinumtoxinA for Sialorrhea in Children: SIPEXI
por: Berweck, Steffen, et al.
Publicado: (2021)

Botulinum Toxin A in the Management of Pediatric Sialorrhea: A Systematic Review
por: Heikel, Tiffany, et al.
Publicado: (2022)

Efficacy of scopolamine transdermal patch in children with sialorrhea in a pediatric tertiary care hospital
por: Al Jeraisy, Majed, et al.
Publicado: (2020)

Cost-Effectiveness of IncobotulinumtoxinA in the Treatment of Sialorrhea in Patients with Various Neurological Conditions
por: Makino, Koji, et al.
Publicado: (2020)

Salivary gland ablation: introducing an interventional radiology treatment alternative in the management of sialorrhea
por: Begley, Katherine A., et al.
Publicado: (2020)

The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea: A systematic review
por: Van der Poorten, Thomas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qoh2aqt8lpkv400b856lk0d4nl